bpc-157 recommended cycle length days human use Dosing (Common Protocols), 🔹 Oral / Subcutaneous, • 500 mcg daily, • Duration: 6 weeks, 🔹 Intramuscular / Peritendinous, • 1 mg daily, • Duration: 6 weeks, ⚠️ Note:, Not approved by FDA or BPC-157 vs TB-500: Complete Comparison

In an attempt to make sense of all this, CBC spoke with Bob Hancock, a microbiologist at the University of British Columbia who studies infectious diseases and the immune system

For many research protocols, particularly those involving long-term observations or where ease of administration is a significant factor, an oral compound is often the first choice

If reconstituted in plain sterile water without preservative, the solution should ideally be aliquoted into single-use volumes and used within 48-72 hours refrigerated, or frozen at -20C for extended storage up to several weeks

, stable in human gastric juice for more than 24 h (12, 13)), in the same dose-regimens, BPC 157 protected against various agents or procedures that would otherwise have lead to severe liver lesions (29-31) or CNS disturbances (16-23)

The under-carboxylated form of OC has a reduced affinity for hydroxyapatite

Only BPC 157 has the same regimens, as used in the gastrointestinal healing studies, improving these lesions healing, accurately implementing its own healing angiogenic effect (Seiwerth et al., 2018)